Evidence map›Paper›PMID 22486270›Full record

ArticleJournal of the American Chemical Society2012

Origins of enantioselectivity during allylic substitution reactions catalyzed by metallacyclic iridium complexes.

Sherzod T Madrahimov, John F Hartwig

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Chiral Amines via Enantioselective π-Allyliridium-Accounts of chemical research · 2022
    Article
  8. Article
  9. Article
  10. Intermolecular Stereoselective Iridium-Catalyzed Allylic Alkylation: An Evolutionary Account.Synlett : accounts and rapid communications in synthetic organic chemistry · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Origins of Regioselectivity in Iridium Catalyzed Allylic Substitution.Journal of the American Chemical Society · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sherzod T MadrahimovDepartment of Chemistry, University of Illinois, 600 South Mathews Avenue, Urbana, Illinois 61801, United States.
John F Hartwig

Funding

Mechanism and Development of Catalysts for the Synthesis of Amines, Ethers, and SR37GM055382 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HARTWIG, JOHN F · 2009 to 2018
$4.4M
TRANSITION METAL-CATALYZED SYNTHESIS OF AMINES AND ETHERR01GM055382 · NIGMS · YALE UNIVERSITY · PI HARTWIG, JOHN F · 2001 to 2008
$2.5M
PALLADIUM CATALYZED FORMATION OF ARYLAMINE AND ARYLETHERR29GM055382 · NIGMS · YALE UNIVERSITY · PI HARTWIG, JOHN F · 1997 to 2000
$185k
NIGMS NIH HHS GM-55382NIGMS NIH HHS R01 GM055382NIGMS NIH HHS R29 GM055382NIGMS NIH HHS R37 GM055382
6 · The paper itself

Abstract

In depth mechanistic studies of iridium catalyzed regioselective and enantioselective allylic substitution reactions are presented. A series of cyclometalated allyliridium complexes that are kinetically and chemically competent to be intermediates in the allylic substitution reactions was prepared and characterized by 1D and 2D NMR spectroscopies and single-crystal X-ray difraction. The rates of epimerization of the less thermodynamically stable diastereomeric allyliridium complexes to the thermodynamically more stable allyliridium stereoisomers were measured. The rates of nucleophilic attack by aniline and by N-methylaniline on the isolated allyliridium complexes were also measured. Attack on the thermodynamically less stable allyliridium complex was found to be orders of magnitude faster than attack on the thermodynamically more stable complex, yet the major enantiomer of the catalytic reaction is formed from the more stable diastereomer. Comparison of the rates of nucleophilic attack to the rates of epimerization of the diastereomeric allyliridium complexes containing a weakly coordinating counterion showed that nucleophilic attack on the less stable allyliridium species is much faster than conversion of the less stable isomer to the more stable isomer. These observations imply that Curtin-Hammett conditions are not met during iridium catalyzed allylic substitution reactions by η(3)-η(1)-η(3) interconversion. Rather, these data imply that when these conditions exist for this reaction, they are created by reversible oxidative addition, and the high selectivity of this oxidative addition step to form the more stable diastereomeric allyl complex leads to the high enantioselectivity. The stereochemical outcome of the individual steps of allylic substitution was assessed by reactions of deuterium-labeled substrates. The allylic substitution was shown to occur by oxidative addition with inversion of configuration, followed by an outer sphere nucleophilic attack that leads to a second inversion of configuration. This result contrasts the changes in configuration that occur during reactions of molybdenum complexes studied with these substrates previously. In short, these studies show that the factors that control the enantioselectivity of iridium-catalyzed allylic substitution are distinct from those that control enantioselectivity during allylic substitution catalyzed by palladium or molybdenum complexes and lead to the unique combination of high regioselectivity, enantioselectivity, and scope of reactive nucleophile.

Indexed as

AlkenesAminesCatalysisIridiumKineticsModels, MolecularMolecular ConformationMolybdenumOrganometallic CompoundsPalladiumStereoisomerismSubstrate SpecificityAlkenesAminesIridiumMolybdenumOrganometallic CompoundsPalladium

Identifiers

PMID22486270
PMCPMC3368983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.